Work with NEUVIOR
Bring one medicines workflow. Leave with a clearer decision.
Start narrow. NEUVIOR offers bounded, evidence-led reviews for medicines implementation, decision provenance and market or supply governance. The first task is to determine whether the work is justified and what would stop it.
Proposal, not a validated service claimThree review routes
Choose the decision that is currently stuck.
The route is selected by the decision, not by a generic innovation brief. Each review begins with a bounded question and ends with a stated progression or stop condition.
Medicines implementation readiness
Examine the dependencies between recommendation, funding, pathway readiness, clinical offering, uptake and review.
Proposed engagementDecision provenance
Trace which evidence and AI-assisted suggestions influenced a consequential decision, who retained authority and how challenge or override works.
Proposed engagementSupply and market governance
Map sources, responsibilities, escalation and jurisdiction boundaries around one defined medicine or operating question.
Proposed engagementQualification
Useful work begins with authority and a credible baseline.
Bring one decision, a named sponsor or owner, the non-confidential evidence already available and the timeframe that matters. Do not submit patient-identifiable, confidential clinical, credential or security-sensitive information through the website.
- 01
Decision
The specific choice, pathway or failure pattern to examine.
- 02
Authority
Who may decide, approve, challenge or stop the work.
- 03
Evidence
The sources, known unknowns and permissions already in view.
- 04
Outcome
What a better decision would change and how it could be observed.
Practical output
A map that exposes what must happen next.
A justified review can identify the source trail, decision points, responsible roles, blockers, measures and evidence gaps. It can also conclude that NEUVIOR or PHARMORIS cannot yet help.
The review is not legal, regulatory, clinical or procurement advice and does not certify a workflow, product or organisation.
Proceed
A bounded next step has evidence, authority and an accountable owner.
Narrow
The question is useful but the first scope is too broad or under-evidenced.
Stop
The evidence, authority, permissions or buyer need do not justify progression.
Questions and boundaries
Useful questions before we start.
01What can NEUVIOR examine today?
A bounded, non-confidential medicines implementation, decision-provenance or market-governance question. The first output may be a scope, evidence request or justified stop.
02Is this a PHARMORIS deployment or pilot?
No. A scoped conversation does not authorise a pilot or deployment. PHARMORIS remains in controlled, non-production development and requires separate exact-version and adopter gates.
03What should not be submitted?
Do not submit patient-identifiable information, confidential clinical data, credentials, contracts, live security details or other sensitive material through the website.
04What can stop the work?
No accountable sponsor, unclear buyer need, missing evidence rights, no credible baseline, an unsafe scope or an expectation that NEUVIOR will certify, prescribe or provide legal advice.
Start with one decision
Send the problem, not a patient record or a polished pitch.
State the workflow, organisation type, jurisdiction, accountable role, broad timeframe and intended outcome. NEUVIOR will decide whether a bounded conversation is justified.